FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
BeiGene(BGNE) Businesswire·2023-12-23 00:00BeiGene(BGNE) Businesswire·2023-12-23 00:00
R1BeiGene(BGNE) Businesswire·2023-12-23 00:00 R1BeiGene(BGNE) Businesswire·2023-12-23 00:00